Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Metformin Use in Young, Healthy Adults
NCT06638671Phase 4Completed
- Sponsor
- University of Virginia
- Start
- Jan 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of liquid metformin (Aspargo Labs) (2 arms), sponsored by University of Virginia. Primary endpoints: Exercise capacity at 6 weeks, Lactate threshold at 6 weeks and 3 more. Started Jan 2025; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
Beyond the preview
Go deeper on NCT06638671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06638671.